TY - JOUR
T1 - Somatostatin does not cause sustained fasting hyperglycemia in man
AU - Rizza, R.
AU - Verdonk, C.
AU - Miles, J.
AU - Service, F. J.
AU - Haymond, M.
AU - Gerich, J.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1979
Y1 - 1979
N2 - Somatostatin inhibits both insulin and glucagon secretion; its short-term infusion causes a transient decrease in plasma glucose followed by modest hyperglycemia in man, suggesting that insulin deficiency per se is sufficient to cause fasting hyperglycemia. If this is true, then prolonged inhibition of insulin secretion should result in persistent and more progressive hyperglycemia. On the other hand, if glucagon modifies the metabolic consequences of insulin deficiency, then prolonged inhibition of secretion of both insulin and glucagon might not result in sustained hyperglycemia. To examine these alternatives, changes in plasma glucose, insulin and glucagon, as well as glucose turnover and glucose balance during prolonged infusions of somatostatin (for 12 hr) were studied.
AB - Somatostatin inhibits both insulin and glucagon secretion; its short-term infusion causes a transient decrease in plasma glucose followed by modest hyperglycemia in man, suggesting that insulin deficiency per se is sufficient to cause fasting hyperglycemia. If this is true, then prolonged inhibition of insulin secretion should result in persistent and more progressive hyperglycemia. On the other hand, if glucagon modifies the metabolic consequences of insulin deficiency, then prolonged inhibition of secretion of both insulin and glucagon might not result in sustained hyperglycemia. To examine these alternatives, changes in plasma glucose, insulin and glucagon, as well as glucose turnover and glucose balance during prolonged infusions of somatostatin (for 12 hr) were studied.
UR - http://www.scopus.com/inward/record.url?scp=0018634206&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018634206&partnerID=8YFLogxK
U2 - 10.1055/s-0028-1095806
DO - 10.1055/s-0028-1095806
M3 - Article
C2 - 395056
AN - SCOPUS:0018634206
SN - 0018-5043
VL - 11
SP - 643
EP - 644
JO - Hormone and Metabolic Research
JF - Hormone and Metabolic Research
IS - 11
ER -